Howard Bailey Securities, LLC Roivant Sciences Ltd. Transaction History
Howard Bailey Securities, LLC
- $248 Billion
- Q1 2025
A detailed history of Howard Bailey Securities, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Howard Bailey Securities, LLC holds 11,182 shares of ROIV stock, worth $129,934. This represents 0.05% of its overall portfolio holdings.
Number of Shares
11,182
Previous 11,205
0.21%
Holding current value
$129,934
Previous $133 Million
14.88%
% of portfolio
0.05%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
322Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$765 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$721 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$556 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$512 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$411 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.18B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...